The next version of the DSM is being planned with some potentially major changes. Will we get a giant leap forward or just ...

In recent years, Nevada has faced a growing addiction crisis, with alarming statistics highlighting the urgent need for effective substance abuse recovery solutions. According to the Nevada Department ...

The American Cancer Society released its 2026 Facts & Figures, revealing that, for the first time ever, seven in ten cancer ...

Researchers conducted a cross-sectional study to examine hepatitis B treatment trends among adults in the United States.

A paper published in Biology Methods and Protocols, indicates that a new computational method may help researchers identify ...

Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...

The current edition of the Diagnostic and Statistical Manual is known as the DSM-5. What will the next version be called?

FAYETTEVILLE, GA, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- Understanding why cancer cells rely on specific ...

Key highlights from the Type C FDA meeting include: FDA confirms the approach that the proposed primary endpoint of the ...

Belite Bio completes enrollment in phase 2/3 DRAGON II clinical trial evaluating tinlarebant for the treatment of Stargardt ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical ...

Centanafadine is a first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor designed to address the core symptoms of ADHD in children and adults.